Interactions with antiepileptic drugs
- PMID: 16736
- DOI: 10.2165/00003495-197713040-00002
Interactions with antiepileptic drugs
Abstract
Most of the currently available antiepileptic drugs have a low therapeutic ratio and therefore a drug interaction causing elevation of the serum level of one of these compounds can readily lead to drug intoxication. Phenytoin, in particular, is vulnerable because its metabolism is dose-related and at therapeutic serum levels the enzyme system involved in its degradation is easily inhibited by concurrent drug administration. As multiple drug therapy has traditionally been practised in the management of epilepsy, clinically important interactions are common. Furthermore, most of the drugs used in the treatment of major epilepsies are potent inducers of hepatic microsomal enzymes and can therefore stimulate the metabolism of concurrently-administered drugs to such an extent that they may be rendered ineffective. The use of one drug alone is recommended, where possible, in the management of epilepsy.
Similar articles
-
[Drug interactions in antiepileptic combination therapy].Dtsch Med Wochenschr. 1979 Feb 16;104(7):260-5. doi: 10.1055/s-0028-1103882. Dtsch Med Wochenschr. 1979. PMID: 33033 German. No abstract available.
-
Clinically significant pharmacokinetic drug interactions with carbamazepine. An update.Clin Pharmacokinet. 1996 Sep;31(3):198-214. doi: 10.2165/00003088-199631030-00004. Clin Pharmacokinet. 1996. PMID: 8877250 Review.
-
Long-term use of the major anticonvulsant drugs.Am Fam Physician. 1978 Oct;18(4):107-16. Am Fam Physician. 1978. PMID: 360810
-
Pharmacologic interactions between valproate and other drugs.Am J Med. 1988 Jan 25;84(1A):29-33. doi: 10.1016/0002-9343(88)90054-x. Am J Med. 1988. PMID: 3146222
-
Pharmacokinetic interactions with antiepileptic drugs.Clin Pharmacokinet. 1982 Jan-Feb;7(1):57-84. doi: 10.2165/00003088-198207010-00004. Clin Pharmacokinet. 1982. PMID: 7042173 Review.
Cited by
-
The risk-benefit ratio of anticonvulsant drugs.Med Toxicol Adverse Drug Exp. 1987 Sep-Oct;2(5):324-37. doi: 10.1007/BF03259952. Med Toxicol Adverse Drug Exp. 1987. PMID: 3312929 Review.
-
Interaction between phenytoin and antacids.Br J Clin Pharmacol. 1978 Aug;6(2):177-9. doi: 10.1111/j.1365-2125.1978.tb00848.x. Br J Clin Pharmacol. 1978. PMID: 678395 Free PMC article. Clinical Trial. No abstract available.
-
Antiepileptic drug toxicity: definition and mechanism of action.Ital J Neurol Sci. 1986 Apr;7(2):209-22. doi: 10.1007/BF02230884. Ital J Neurol Sci. 1986. PMID: 3013801 Review.
-
Some clinical pharmacological aspects of n-dipropylacetamide.Ital J Neurol Sci. 1980 Oct;1(4):245-9. doi: 10.1007/BF02336705. Ital J Neurol Sci. 1980. PMID: 6802780
-
Clinical pharmacokinetics of phenytoin.Clin Pharmacokinet. 1979 May-Jun;4(3):153-69. doi: 10.2165/00003088-197904030-00001. Clin Pharmacokinet. 1979. PMID: 383353 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials